Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. - Krüger,S.; Ewig,S.; Marre,R.; Papassotriou,J.; Richter,K.; Baum,H von.; Suttorp,N.; Welte,T. (Eur Respir J, 2006)